Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection With Proposed Merger With TuHURA Biosciences, Trading to Begin Under New Name and Symbol "HURA" on October 17, Reducing Outstanding Shares to 1.6M

Author: Benzinga Newsdesk | October 16, 2024 11:59am

Posted In: KTRA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist